Clinical Trials Browser

Phase 2 × fresolimumab × Clear all

NCT01472731 2024-05-06

Safety and Imaging Study of GC1008 in Glioma

Phase 2 Completed

Brain Neoplasms

NCT01112293 2020-04-10

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Phase 2 Completed

14 enrolled 10 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Phase 2 Completed

23 enrolled 8 charts

Breast Neoplasms, Camurati-Engelmann Syndrome